14:35 ~ 14:45 |
What is the Optimal Therapy for BCG Unresponsive High-Risk NMIBC: Intravesical Chemotherapy or Systemic Therapy? |
Hyeong Dong YUK |
|
14:45 ~ 14:55 |
Optimal Strategy of Trimodality Therapy: Who, How, and When? |
Wan SONG |
|
14:55 ~ 15:15 |
Restaging TURBT Prior to Definitive Locoregional Therapy |
Seth LERNER |
|